Kolmar BNH Overview
- Year Founded
-
2004
- Status
-
Public
- Employees
-
484
- Stock Symbol
-
200130
- Investments
-
1
- Share Price
-
$5.63
- (As of Friday Closing)
Kolmar BNH General Information
Description
Kolmar BNH Co Ltd is a Korea-based company, engaged in develops core ingredients for health functional foods and cosmetics. The company commercialize materials developed using natural products and produce and sell health functional foods and cosmetics through ODM/OEM methods. The company is engaged in ODM/OEM businesses for various health functional foods and cosmetics, focusing on improving immune function, gut health, and blood sugar levels. The company derives maximum revenue from health functional food business. The company exports its products in China, the United States, Taiwan, Russia, and Japan.
Contact Information
Website
www.kolmarbnh.co.krCorporate Office
- 18, Saimdang-ro, Seocho-dong, Seocho-gu
- Seoul, 06641
- South Korea
Corporate Office
- 18, Saimdang-ro, Seocho-dong, Seocho-gu
- Seoul, 06641
- South Korea
Kolmar BNH Stock Performance
As of 20-Nov-2026, Kolmar BNH’s stock price is $5.63. Its current market cap is $159M with 28.3M shares.
(As of Friday Closing)
| Stock Price | Previous Close | 52 wk Range | Market Cap | Shares | Average Volume | EPS |
|---|---|---|---|---|---|---|
| $5.63 | $5.75 | $4.94 - $10.59 | $159M | 28.3M | 71K | -$0.04 |
Kolmar BNH Financials Summary
As of 30-Jun-2026, Kolmar BNH has a trailing 12-month revenue of $371M.
|
In Thousands, USD |
TTM 30-Jun-2026 | FY 2025 31-Dec-2025 | FY 2024 31-Dec-2024 | FY 2023 31-Dec-2023 |
|---|---|---|---|---|
| EV | 167,214 | 328,364 | 330,644 | 488,047 |
| Revenue | 370,835 | 403,956 | 451,206 | 443,269 |
| EBITDA | 16,953 | (346) | 34,526 | 34,422 |
| Net Income | (1,075) | (15,929) | 13,231 | 15,075 |
| Total Assets | 369,855 | 451,169 | 469,031 | 538,930 |
| Total Debt | 72,491 | 149,640 | 152,671 | 161,501 |
Kolmar BNH Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Kolmar BNH Patents
Kolmar BNH Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| WO-2026135373-A1 | Composition for enhancing immunity | Pending | 20-Dec-2024 | ||
| AU-2025374364-A1 | Composition for enhancing immunity comprising enzyme-treated product of polysaccharides or purified fraction thereof | Pending | 20-Dec-2024 | ||
| EP-4789551-A1 | Composition for enhancing immunity comprising enzyme-treated product of polysaccharides or purified fraction thereof | Pending | 20-Dec-2024 | ||
| WO-2026135371-A1 | Composition for enhancing immunity comprising enzyme-treated product of polysaccharides or purified fraction thereof | Pending | 20-Dec-2024 | ||
| EP-4837428-A1 | Composition for enhancing immunity comprising polysaccharide enzyme-treated product or purified fraction thereof | Pending | 20-Dec-2024 | A23L33/105 |
Kolmar BNH Signals
Kolmar BNH Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
Kolmar BNH Investments (1)
Kolmar BNH’s most recent deal was a Later Stage VC with PlanTFarm for . The deal was made on 14-Jul-2021.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| PlanTFarm | 14-Jul-2021 | Later Stage VC | Other Agriculture |
Kolmar BNH ESG
Risk Overview
Risk Rating
Updated November, 04, 2026
30.99 | High Risk
Risk Scale
A lower score indicates better sustainability
Negl
0-10
Low
10-20
Med
20-30
High
30-40
Severe
40+
Exposure
Exposure refers to the extent to which a company is exposed to different material ESG issues
Management
Management is related to actions taken to manage ESG issues
Peers Analysis
Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.
Global
Covered Companies
of 13,593
Rank
Percentile
Household Products
Industry
of 104
Rank
Percentile
Personal Products
Subindustry
of 84
Rank
Percentile
Kolmar BNH FAQs
-
When was Kolmar BNH founded?
Kolmar BNH was founded in 2004.
-
Where is Kolmar BNH headquartered?
Kolmar BNH is headquartered in Seoul, South Korea.
-
What is the size of Kolmar BNH?
Kolmar BNH has 484 total employees.
-
What industry is Kolmar BNH in?
Kolmar BNH’s primary industry is Pharmaceuticals.
-
Is Kolmar BNH a private or public company?
Kolmar BNH is a Public company.
-
What is Kolmar BNH’s stock symbol?
The ticker symbol for Kolmar BNH is 200130.
-
What is the current stock price of Kolmar BNH?
As of 20-Nov-2026 the stock price of Kolmar BNH is $5.63.
-
What is the current market cap of Kolmar BNH?
The current market capitalization of Kolmar BNH is $159M.
-
What is Kolmar BNH’s current revenue?
The trailing twelve month revenue for Kolmar BNH is $371M.
-
What is Kolmar BNH’s annual earnings per share (EPS)?
Kolmar BNH’s EPS for 12 months was -$0.04.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process